View Future GrowthMegaMD 過去の業績過去 基準チェック /46MegaMDの収益は年間平均-27.4%の割合で減少していますが、 Consumer Services業界の収益は年間 増加しています。収益は年間4.1% 21.3%割合で 減少しています。 MegaMDの自己資本利益率は4.8%であり、純利益率は8.9%です。主要情報-27.40%収益成長率-27.56%EPS成長率Consumer Services 業界の成長13.57%収益成長率-21.27%株主資本利益率4.78%ネット・マージン8.93%前回の決算情報30 Jun 2025最近の業績更新分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...すべての更新を表示Recent updatesお知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Koreaお知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).分析記事 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South KoreaValuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.分析記事 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...分析記事 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.分析記事 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...分析記事 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...分析記事 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.分析記事 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).分析記事 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...収支内訳MegaMD の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A133750 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費30 Jun 2535,1933,14114,617031 Mar 2536,1622,67114,781031 Dec 2436,4913,78314,481030 Sep 2436,0891,50613,156030 Jun 2435,8401,31615,213031 Mar 2436,06042116,161031 Dec 2336,041-3,19718,195030 Sep 2337,370-5,54921,707030 Jun 2343,915-5,14024,276031 Mar 2354,107-2,44927,048031 Dec 2264,4682,11328,825030 Sep 2270,4813,64131,470030 Jun 2274,3285,86931,702031 Mar 2277,1996,73732,117031 Dec 2179,4356,65032,538030 Sep 2181,3646,65731,421030 Jun 2182,7245,87332,118031 Mar 2182,3956,19631,756031 Dec 2082,4404,89732,419030 Sep 2081,3563,95233,580030 Jun 2079,9992,76834,198031 Mar 2080,18095936,388031 Dec 1980,37441337,691030 Sep 1980,362-94342,319030 Jun 1978,330-98442,917031 Mar 1976,491-27842,598031 Dec 1875,3281,11042,567030 Sep 1873,0455738,413030 Jun 1873,156-49338,946031 Mar 1870,822-1,83438,965031 Dec 1769,202-1,88538,328030 Sep 1762,75680435,088030 Jun 1762,5281,09734,741031 Mar 1760,6211,81333,439031 Dec 1660,0763,13832,376030 Sep 1663,4373,06234,100030 Jun 1662,4994,58732,302031 Mar 1665,6377,33131,426031 Dec 1566,9368,75730,387030 Sep 1567,8858,43328,1900質の高い収益: A133750は 高品質の収益 を持っています。利益率の向上: A133750の現在の純利益率 (8.9%)は、昨年(3.7%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A133750の収益は過去 5 年間で年間27.4%減少しました。成長の加速: A133750の過去 1 年間の収益成長率 ( 138.8% ) は、5 年間の平均 ( 年間-27.4%を上回っています。収益対業界: A133750の過去 1 年間の収益成長率 ( 138.8% ) はConsumer Services業界37.9%を上回りました。株主資本利益率高いROE: A133750の 自己資本利益率 ( 4.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YConsumer-services 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/28 22:43終値2026/05/28 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MegaMD Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...
お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
お知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).
Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.
New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).
New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).
分析記事 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.
分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).
お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.
分析記事 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.
Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...
Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...
分析記事 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...
New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).
Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.
分析記事 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...
分析記事 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...
分析記事 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...
Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.
分析記事 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).
分析記事 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...
Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.
分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...